Article info
PDFPostScript
Letter
ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival
- Correspondence to Markus Weber, MD, Neuromuscular Diseases Unit, Kantonsspital St.Gallen, 9007 St. Gallen, Switzerland; markus.weber{at}kssg.ch
Citation
ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival
Publication history
- Received January 20, 2011
- Revised April 8, 2011
- Accepted May 23, 2011
- First published June 23, 2011.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.